Can Vitamin B2 Help Cancer Cells Survive

By Marwan Ben A
> The Surprising Link Between Vitamin B2 and Cancer Cell Survival
A common vitamin found in eggs, dairy, and leafy greens may be secretly shielding cancer cells from natural destruction.
vitamin B2 helps cancer cells resist ferroptosis, a natural form of cell death.


Vitamin B2, also known as riboflavin, is best known for its everyday role in helping the body produce energy and keep skin, eyes, and the nervous system healthy. But new research from scientists in Germany has uncovered a far less expected side to this common nutrient: it may also help cancer cells survive. According to a study from Julius-Maximilians-Universität Würzburg, vitamin B2 appears to protect tumor cells from a natural form of cell death called ferroptosis, giving researchers a new angle from which to attack cancer at the cellular level.

What Is Vitamin B2 and Why Does the Body Need It

Riboflavin is a water-soluble vitamin that the human body cannot produce on its own, so it must be obtained through food. Good dietary sources include dairy products, eggs, meat, and leafy green vegetables. Once absorbed, vitamin B2 is converted into molecules that support several essential biological functions, including protecting cells from oxidative stress. This protective role is generally considered a health benefit, which is exactly what makes the new findings so unexpected.

How Ferroptosis Works as a Natural Defense Mechanism

Ferroptosis is a distinct form of programmed cell death, separate from more familiar processes like apoptosis. Rather than being caused by a genetic signal, it is driven by iron-related stress that leads to damage in the cell's membrane through a process called lipid peroxidation. When this damage builds up beyond a certain point, the cell is essentially marked for controlled destruction. This mechanism acts as one of the body's natural safeguards, allowing damaged or potentially dangerous cells, including cancerous ones, to be eliminated without triggering harmful inflammation in the surrounding tissue.

The Unexpected Role of Vitamin B2 in Protecting Tumor Cells

The research team, led by Professor José Pedro Friedmann Angeli at the Rudolf Virchow Centre in Würzburg, focused on a protein called ferroptosis suppressor protein 1, or FSP1. This protein is one of the cell's main defenses against ferroptosis, helping to regenerate antioxidants that keep the cell membrane intact. The researchers discovered that vitamin B2 plays a crucial role in stabilizing FSP1 and supporting its protective function. In cancer cells, this means that riboflavin indirectly helps tumors resist the very process that would otherwise trigger their destruction. In laboratory experiments, depriving cancer cells of vitamin B2 made them noticeably more vulnerable to ferroptosis.

Roseoflavin: Turning a Vitamin's Defense Into a Vulnerability

Understanding this defense mechanism was only the first step. To test whether it could be exploited, the researchers turned to a naturally occurring compound called roseoflavin, which is produced by bacteria and structurally resembles vitamin B2. Because of this similarity, roseoflavin can interfere with the way cancer cells use riboflavin, effectively acting as a decoy that disrupts FSP1's protective activity from within the cell. When roseoflavin was applied to cancer cell models in the lab, it triggered ferroptosis even at low concentrations, offering an early proof of concept that this defense pathway can be deliberately switched off.

Why This Discovery Matters for Future Cancer Treatment

This research points toward a possible new strategy for cancer therapy: instead of attacking cancer cells directly, treatments could focus on cutting off the metabolic support systems, such as vitamin B2 pathways, that allow tumors to resist natural cell death. Because ferroptosis has also been linked to neurodegenerative diseases and tissue damage following organ transplantation or ischemia-reperfusion injury, a deeper understanding of how riboflavin influences this process could have implications that extend well beyond oncology.

What This Does Not Mean for Everyday Vitamin B2 Intake

It is important to understand what this study does not show. The experiments were conducted on cancer cells in laboratory conditions, not in humans, and the findings do not suggest that people should restrict their dietary vitamin B2 intake in an attempt to fight cancer. Riboflavin remains an essential nutrient that supports healthy skin, energy metabolism, and normal cell function throughout the body, and a genuine deficiency can cause real harm well before it would have any meaningful effect on a tumor. Any future therapy would need to target cancer cell chemistry with far more precision than a change in diet ever could, and such treatments would still need to go through extensive safety and efficacy testing in animals and humans before they could be considered for clinical use.


This research adds an intriguing new layer to our understanding of how cancer cells survive and resist treatment. Vitamin B2 remains an important part of a healthy diet, but its newly discovered role in supporting ferroptosis resistance opens a promising avenue for future, more targeted cancer therapies. As with most early-stage laboratory findings, translating this discovery into an approved treatment will take years of further research, but it represents a meaningful step forward in understanding the metabolic vulnerabilities of cancer cells.

References